← ANALYSTS · TIPRANKS

Bradley Canino · Guggenheim

#1614among 12,504 TipRanks analysts★★★★★★★★★★
Hits 46% 114 of 246 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +10.8% Over a year after the rating, TipRanks’ measure
Our companies rated now 18 Buy / hold / sell: 17 / 1 / 0
Upside of the analyst’s targets +169.4% Average over 17 current targets, to the last price
The market’s answer to the ratings +2.4% Day-0 move against SPY in the rating’s direction, average over 11 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Sep 24on TipRanks Sep 25 08:31 DMRAIWMDamora Therapeutics · $1.1B Reiterated Buy $40.00 → $60.00+50.0% +225.4% −0.7%next day +1.4% · 5 days +0.2%
Sep 15on TipRanks 16:25 FTHFaeth Therapeutics · $517M Initiated Buy $70.00 +272.3% −2.8%next day +1.5% · 5 days −9.9%
Aug 30on TipRanks Aug 31 07:25 KYMRIWMKymera Therapeutics · $9.0B Assigned Buy $135 → $170+25.9% +62.2% +0.9%next day +0.9% · 5 days −1.8%
Aug 16on TipRanks Aug 17 07:20 CELCIWMCelcuity · $2.9B Assigned Buy $165 → $175+6.1% +209.3% +1.0%next day +1.5% · 5 days −0.6%
Aug 6on TipRanks Aug 7 07:45 JANXIWMJanux Therapeutics Inc · $1.1B Assigned Buy $58.00 → $55.00−5.2% +233.1% +0.8%next day −2.2% · 5 days −1.8%
Aug 3on TipRanks Aug 4 07:51 ORICIWMOric Pharmaceuticals · $1.3B Reiterated Buy $18.00 +45.7% −5.7%next day +25.3% · 5 days +26.5%
Jul 23on TipRanks Jul 24 07:00 SMMTSummit Therapeutics · $12.4B Assigned Buy $40.00 → $38.00−5.0% +159.7% +2.9%next day −8.9% · 5 days −10.8%
Jul 19on TipRanks Jul 20 05:15 ANTXIWMAN2 Therapeutics, Inc. · $136M Initiated Buy $9.00 +166.3% +2.7%next day +3.3% · 5 days +3.1%
Jul 14on TipRanks Jul 15 10:46 SNDXIWMSyndax Pharmaceuticals · $1.2B Reiterated Buy $31.00 +140.3% +5.1%next day −2.9% · 5 days −5.7%
Jun 1on TipRanks 07:55 OLMAIWMOlema Pharmaceuticals · $601M Reiterated Buy $38.00 → $35.00−7.9% +431.9% −3.9%next day −16.0% · 5 days −19.1%
May 26on TipRanks 10:50 BCAXIWMBicara Therapeutics Inc. · $1.2B Reiterated Buy $42.00 +150.3% +0.7%next day −1.8% · 5 days −11.8%
May 25on TipRanks May 26 06:50 RLAYIWMRelay Therapeutics · $3.8B Reiterated Buy $22.00 → $26.00+18.2% +59.7% +4.1%next day +1.9% · 5 days +9.6%
Apr 29on TipRanks Apr 30 07:00 CBIOIWMCrescent Biopharma · $464M Reiterated Buy $35.00 +195.6% −12.6%next day +5.8% · 5 days −16.9%
Apr 15on TipRanks Apr 14 16:20 TYRAIWMTyra Bioscience · $1.3B Initiated Buy $54.00 +191.6% −1.6%next day +0.2% · 5 days +5.2%
Mar 10on TipRanks Mar 11 06:55 CGEMIWMCullinan Management · $901M Reiterated Buy $30.00 +132.0% −2.5%next day −3.9% · 5 days −8.9%
Feb 27on TipRanks Mar 2 07:01 CGONIWMCG Oncology, Inc. · $5.5B Reiterated Buy $90.00 +50.4% +5.3%next day −1.8% · 5 days +7.2%
Feb 26on TipRanks Feb 27 07:30 CCCCIWMC4 Therapeutics · $321M Reiterated Buy $7.00 +153.2% +0.9%next day −2.4% · 5 days +10.2%
Dec 3on TipRanks 12:40 BDTXIWMBlack Diamond Therapeutics · $100M Downgrade Hold — — −22.4%next day +0.7% · 5 days −1.3%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗